Year-End Amendment
DOW LOHNES GOVERNMENT STRATEGIES LLC for APOTEX CORP
Client
Income
$40,000
Expenses
—
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| Year-End Report | Feb 14, 2008 | $40,000 | Replaced |
| Year-End Amendment (this page) | Mar 18, 2008 | $40,000 | Yes |
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
H.R. 3700 Fair Medicaid Drug Payment Act of 2007, provisions related to regulation of generic drugs and consumer access; H.R. 1902 Protecting Consumer Access to Generic Drugs Act of 2007, all provisions; H.R. 3610 Food and Drug Import Safety Act of 2007, provisions related to drug safety; FDA approval of biogenerics
| Lobbyist | Covered position, as disclosed |
|---|---|
| ERIC S KESSLER | CHIEF OF STAFF, HON. JOHN D. DINGELL |
| JESSICA M LENARD | LEGISLATIVE ASSISTANT, HON. RICHARD J. DURBIN |
| KENNETH D SALOMON | N/A |
| STEPHEN C SAYLE | N/A |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.